Results 181 to 190 of about 58,793 (273)

Comprehensive <i>BRCA1/2</i> mutation landscape in prostate cancer in the UAE and Arab population. [PDF]

Front Cell Dev Biol
Al Shareef ZM, Al-Shahrabi RM, Bhamidimarri PM, Yener B, Bouzid A, Hamad AM, Murad S, Elbarkouky A, Saheb Sharif-Askari F, Bendardaf R, Hamoudi RA, Hachim MY.   +11 more
europepmc   +1 more source

The Changing Landscape of Urological Surgery: 10-Year Trends in Benign Prostatic Hyperplasia and Upper Urinary Tract Stone Management in the San-in Region, Japan. [PDF]

Yonago Acta Med
Kimura Y, Morizane S, Yamamoto A, Omatsu R, Yamane H, Teraoka S, Nishikawa R, Yamaguchi N, Hikita K, Takenaka A.   +9 more
europepmc   +1 more source

Hormone antagonists for two-pronged attack on BPH [PDF]

Nature Reviews Urology, 2012
openaire   +2 more sources

Curcumin versus placebo in benign prostatic hyperplasia: a systematic review and meta-analysis. [PDF]

Eur J Clin Pharmacol
Santana DS, Porto BC, Cardoso RB, Lopes GMM, Gimenez LGS, Passerotti CC, Maia R, Almeida FG, da Silva Sardenberg RA, da Cruz JAS.   +9 more
europepmc   +1 more source

Botanico Periodicum Huntianum BPH [PDF]

Hunt Botanical Library, Lawrence, George Hill Mathewson 1910-1978   +1 more
core  

Single-Cell and Spatial Transcriptomics Uncover Immune Dynamics and Cellular Heterogeneity in Benign Prostatic Hyperplasia and Prostate Cancer Transition. [PDF]

MedComm (2020)
Luo Y, Zhong H, Shang T, Hu B, Yuan D, Jia X, Lin R, Wang Z, Fang Y, Zhu G, Song J, Liu Z, Yan B, Sun F, Jia Z, Yu Y, Mao L, Huang H, Zhu J.   +18 more
europepmc   +1 more source

Multi-Center, Real-World Registry Study of the UroLift Prostatic Urethral Lift (PUL) for Benign Prostatic Hyperplasia (BPH) in Japan. [PDF]

Int J Urol
Masumori N, Takahashi S, Anan G, Endo F, Furuta A, Haga K, Hatanaka M, Kato S, Komai Y, Kyoda Y, Matsuyama N, Murayama S, Nagamatsu H, Obinata D, Sekiguchi Z, Waseda Y.   +15 more
europepmc   +1 more source

Myricetin alleviates testosterone-induced benign prostatic hyperplasia by attenuating inflammation, oxidative stress, apoptosis and androgen signaling. [PDF]

Sci Rep
Alomari G, Al-Trad B, Qar J, Tahat L, Abu Haija Y, Al-Najjar A, Albokhadaim I, Shousha S, Alameen AO, Shukry M.   +9 more
europepmc   +1 more source

Exploring the potential mechanism of Huang'e capsule against spontaneous benign prostatic hyperplasia in beagle dogs using high-performance liquid chromatography-quadrupole-time-of-flight tandem mass spectrometry, gas chromatography-mass spectrometry, and network pharmacology. [PDF]

J Tradit Chin Med
Aicui MA, Qi P, Dingshi C, Zhonghui W, Chiyang Z, Junfang Z, Jianyan Y, Lei LI, Han Y, Shunheng Y, Jun G, Zuyue S.   +11 more
europepmc   +1 more source

Development and validation of a discrimination model for benign prostatic hyperplasia: key influencing factors, interaction effects, and the protective role of g-tocopherol. [PDF]

Transl Androl Urol
Mao JG.
europepmc   +1 more source